The binding of SDF1 with CXCR4 activates molecular networks of downstream signaling pathways, promoting cell proliferation and movement, inducing immune tolerance and inflammation, affecting migration and homing of hematopoietic stem cells, and stimulating embryonic development, especially malignant tumor growth and progression [10–12]. This evidence concerns the gene CXCR4 and cancer.